Serologic test for syphilis as a surrogate marker for human immunodeficiency virus infection among United States blood donors

Transfusion

Volumn 37, Issue 8, 1997, Pages 836-840

  Herrera, G A ^a   Lackritz, E M ^b   Janssen, R S ^a   Raimondi, V P ^c   Dodd, R Y ^d   Aberle Grasse, J ^e   Petersen, L R ^a,f  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b Division of HIV/AIDS Prevention   (United States)

^c Orkand Corporation   (United States)

^d Biomedical Research and Development   (United States)

^e Jerome H Holland Laboratory   (United States)

^f ROBERT KOCH INSTITUTE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLOOD DONOR; COST; COST BENEFIT ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; SCREENING; SERODIAGNOSIS; SYPHILIS; UNITED STATES; VIRUS TRANSMISSION;

EID: 0030864589     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.1997.37897424407.x     Document Type: Article

References (22)

1. Epstein JS. Food and Drug Administration approach to testing. Consensus Development Conference Presentation. Bethesda: National Institutes of Health, 1995.
2. Chambers RW, Foley HT, Schmidt PJ. Transmission of syphilis by fresh blood components. Transfusion 1969;9:32-4.
3. Risseeuw-Appel IM, Kothe FC. Transfusion syphilis: a case report. Sex Transm Dis 1983;10:200-1.
4. Doll LS, Petersen LR, White CR, et al. Human immunodeficiency virus type 1-infected blood donors: behavioral characteristics and reasons for donation. Transfusion 1991;31:704-9.
5. Bove JR, Chateau G, Holland PV, et al. Does it make sense for blood transfusion services to continue the time-honored syphilis screening with cardiolipin antigen? Vox Sang 1981;41:183-92.
6. Ramsey G, Soltis F, Bowman R, et al. Syphilis serology in blood donors: a possible surrogate marker for human immunodeficiency virus risk. Vox Sang 1991;60:165-8.
7. De Schryver A, Meheus A. Syphilis and blood transfusion: a global perspective. Transfusion 1990;30:844-7.
8. Schreiber GB, Busch MP, Kleinman SH, Korelitz JJ. The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study. N Engl J Med 1996;334:1685-90.
9. Freund RJ, Littell RC. SAS system for regression. 2nd ed. Cary, NC: SAS Institute, 1991.
10. Dean AG, Dean JA, Coulombier D, et al. Epi Info, Version 6: a word processing, database, and statistics program for epidemiology on microcomputers. Atlanta: Centers for Disease Control and Prevention, 1994.
11. Lackritz EM, Satten GA, Aberle-Grasse J, et al. Estimated risk of transmission of the human immunodeficiency virus by screened blood in the United States. N Engl J Med 1995;333:1721-5.
12. Nelson KE, Donahue JG, Munoz A, et al. Transmission of retroviruses from seronegative donors by transfusion during cardiac surgery. A multicenter study of HIV-1 and HTLV-I/II infections. Ann Intern Med 1992;117:554-9.
13. ™ system for syphilis testing (abstract). Transfusion 1991;31(Suppl):75S.
14. Forbes G, Rutter P, Abraham C. Significant cost savings with an automated syphilis screening test (abstract). Transfusion 1991;31(Suppl):75S.
15. Etchason J, Pets L, Keeler E, et al. The cost effectiveness of preoperative autologous blood donations. N Engl J Med 1995;332:719-24.
16. Cumming PD, Schorr JB, Wallace EL. Annual blood facts. Washington, DC: American Red Cross, 1987.
17. Prevention, diagnosis, and management of viral hepatitis: a guide for primary care physicians. Chicago: American Medical Association, 1995.
18. Cross GD, Schalla WO, Hancock JS, et al. Analytic sensitivity and specificity of enzyme immunoassay results in testing for human immunodeficiency virus type 1 antibody. Arch Pathol Lab Med 1992;116:477-81.
19. Schwartz JS, Kinosian BP, Pierskalla WP, Lee H. Strategies for screening blood for human immunodeficiency virus antibody. Use of a decision support system. JAMA 1990;264:1704-10.
20. Zuck TF. Decisions on screening for viral markers in blood donors. Dev Biol Stand 1993;81:91-100.
21. Busch MP, Alter HJ. Will human immunodeficiency virus p24 antigen screening increase the safety of the blood supply and, if so, at what cost? (editorial). Transfusion 1995;35:536-9.
22. Dyckman JD, Storms S, Huber TW. Reactivity of microhemagglutination, fluorescent treponemal antibody absorption, and venereal disease research laboratory tests in primary syphilis. J Clin Microbiol 1980;12:629-30.